Arcadia Biosciences (RKDA) Misses Q4 EPS by 2c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand